MedTrace Logo

Abortive Effect of an Ear Insufflator on Migraine

NCT02614378 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2016-12-14

No results posted yet for this study

Summary

Evaluate the effectiveness of air insufflation in aborting (stopping) an acute episode of migraine and compare it with a placebo effect of using the same procedure but without active insufflation. The insufflation will be used when the subject is experiencing an acute episode of migraine to determine its ability to reduce, if not to completely eliminate the migraine symptoms. Subjects receiving the placebo treatment will be offered the active treatment during the subsequent episode of migraine.

Conditions

Interventions

PROCEDURE

air insufflation

modulated air insufflation of the ear canal

PROCEDURE

placebo

no air will be introduced in the ear canal

Sponsors & Collaborators

  • Carrick Institute for Graduate Studies

    lead OTHER

Principal Investigators

  • Frederick R Carrick, PhD · Carrick Institute for Graduate Studies

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02614378 on ClinicalTrials.gov